Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Active Biotech AB's share price for the quarter that ended in Dec. 2023 was kr1.4032. Active Biotech AB's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 361.74 Mil. Therefore, Active Biotech AB's market cap for the quarter that ended in Dec. 2023 was kr507.59 Mil.
Active Biotech AB's quarterly market cap
stayed the same
from Jun. 2023 (kr372.05 Mil) to Sep. 2023 (kr372.05 Mil) but then
increased
from Sep. 2023 (kr372.05 Mil) to Dec. 2023 (kr507.59 Mil).
Active Biotech AB's annual market cap
increased
from Dec. 2021 (kr318.72 Mil) to Dec. 2022 (kr371.69 Mil) and
increased
from Dec. 2022 (kr371.69 Mil) to Dec. 2023 (kr507.59 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Active Biotech AB's Enterprise Value for Today is kr166.56 Mil.
Active Biotech AB Market Cap Historical Data
The historical data trend for Active Biotech AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Active Biotech AB's Market Cap
For the Biotechnology subindustry, Active Biotech AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Active Biotech AB's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Active Biotech AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Active Biotech AB's Market Cap falls into.
Active Biotech AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Active Biotech AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Active Biotech AB (LTS:0GQU) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Active Biotech AB Market Cap Related Terms
Thank you for viewing the detailed overview of Active Biotech AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0GQU has been successfully added to your 